{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:51:36Z","timestamp":1780321896411,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-09627-8","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T03:46:06Z","timestamp":1681357566000},"page":"6245-6255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Koichiro","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2757-8083","authenticated-orcid":false,"given":"Soichiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kitazume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Waseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minato","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ito","family":"Masaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"9627_CR1","unstructured":"International Agency for Research on Cancer (2020) Cancer Fact Sheets Bladder. World Health Organization, Geneva. Available via https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/30-Bladder-fact-sheet.pdf. Accessed 27 Jul 2022"},{"key":"9627_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","volume":"198","author":"SS Chang","year":"2017","unstructured":"Chang SS, Bochner BH, Chou R et al (2017) Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO Guideline. J Urol 198:552\u2013559","journal-title":"J Urol"},{"key":"9627_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Narumi Y, Altun E et al (2018) Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 74:294\u2013306","journal-title":"Eur Urol"},{"key":"#cr-split#-9627_CR4.1","unstructured":"Expert Panel on Urological I, Allen BC, Oto A et al (2021) ACR Appropriateness Criteria"},{"key":"#cr-split#-9627_CR4.2","doi-asserted-by":"crossref","unstructured":"(R) post-treatment surveillance of bladder cancer: 2021 update. J Am Coll Radiol 18:S126-S138","DOI":"10.1016\/j.jacr.2021.02.011"},{"key":"9627_CR5","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1007\/s00330-019-06117-8","volume":"29","author":"G Barchetti","year":"2019","unstructured":"Barchetti G, Simone G, Ceravolo I et al (2019) Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center. Eur Radiol 29:5498\u20135506","journal-title":"Eur Radiol"},{"key":"9627_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.clgc.2020.03.002","volume":"18","author":"M Marchioni","year":"2020","unstructured":"Marchioni M, Primiceri G, Delli Pizzi A et al (2020) Could bladder multiparametric MRI be introduced in routine clinical practice? Role of the new VI-RADS score: results from a prospective study. Clin Genitourin Cancer 18:409-415.e401","journal-title":"Clin Genitourin Cancer"},{"key":"9627_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.eururo.2019.09.029","volume":"77","author":"F Del Giudice","year":"2020","unstructured":"Del Giudice F, Barchetti G, De Berardinis E et al (2020) Prospective assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its clinical impact on the management of high-risk non-muscle-invasive bladder cancer patients candidate for repeated transurethral resection. Eur Urol 77:101\u2013109","journal-title":"Eur Urol"},{"key":"9627_CR8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2214\/AJR.20.23604","volume":"216","author":"Y Ueno","year":"2021","unstructured":"Ueno Y, Tamada T, Takeuchi M et al (2021) VI-RADS: Multiinstitutional multireader diagnostic accuracy and interobserver agreement study. AJR Am J Roentgenol 216:1257\u20131266","journal-title":"AJR Am J Roentgenol"},{"key":"9627_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","volume":"3","author":"S Woo","year":"2020","unstructured":"Woo S, Panebianco V, Narumi Y et al (2020) Diagnostic performance of Vesical Imaging Reporting and Data System for the prediction of muscle-invasive bladder cancer: a systematic review and meta-analysis. Eur Urol Oncol 3:306\u2013315","journal-title":"Eur Urol Oncol"},{"key":"9627_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00261-021-03365-5","volume":"47","author":"M Pecoraro","year":"2022","unstructured":"Pecoraro M, Del Giudice F, Magliocca F et al (2022) Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report. Abdom Radiol (NY) 47:763\u2013770","journal-title":"Abdom Radiol (NY)"},{"key":"9627_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jmri.27361","volume":"55","author":"V Panebianco","year":"2022","unstructured":"Panebianco V, Pecoraro M, Del Giudice F et al (2022) VI-RADS for bladder cancer: current applications and future developments. J Magn Reson Imaging 55:23\u201336","journal-title":"J Magn Reson Imaging"},{"key":"9627_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.urology.2008.03.017","volume":"72","author":"F Koga","year":"2008","unstructured":"Koga F, Yoshida S, Kawakami S et al (2008) Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology 72:384\u2013388","journal-title":"Urology"},{"key":"9627_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1464-410X.2011.10425.x","volume":"109","author":"F Koga","year":"2012","unstructured":"Koga F, Kihara K, Yoshida S et al (2012) Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients. BJU Int 109:860\u2013866","journal-title":"BJU Int"},{"key":"9627_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/bju.14736","volume":"124","author":"T Kijima","year":"2019","unstructured":"Kijima T, Tanaka H, Koga F et al (2019) Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients. BJU Int 124:242\u2013250","journal-title":"BJU Int"},{"key":"9627_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1464-410X.2008.08297.x","volume":"104","author":"F Koga","year":"2009","unstructured":"Koga F, Kihara K, Fujii Y et al (2009) Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int 104:189\u2013194","journal-title":"BJU Int"},{"key":"9627_CR16","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1007\/s00330-020-07473-6","volume":"31","author":"A Delli Pizzi","year":"2021","unstructured":"Delli Pizzi A, Mastrodicasa D, Marchioni M et al (2021) Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach. Eur Radiol 31:3874\u20133883","journal-title":"Eur Radiol"},{"key":"9627_CR17","unstructured":"Mostfi FK, Sorbin LH, Torioni H (1973) Histrogical typing of urinary bladder tumors. World Health Organization, Geneva. Available via https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/41533\/9241760109_eng.pdf?sequence=1&isAllowed=y. Accessed 27 Jul 2022"},{"key":"9627_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/amj.2020.02.01","volume":"5","author":"H Tanaka","year":"2020","unstructured":"Tanaka H, Kijima T, Fujii Y (2020) Bladder preservation therapy in muscle-invasive bladder cancer: current evidence and future perspectives. AME Med J 5:16\u201316","journal-title":"AME Med J"},{"key":"9627_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2214\/AJR.10.4632","volume":"196","author":"S Yoshida","year":"2011","unstructured":"Yoshida S, Masuda H, Ishii C et al (2011) Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. AJR Am J Roentgenol 196:110\u2013116","journal-title":"AJR Am J Roentgenol"},{"key":"9627_CR20","doi-asserted-by":"crossref","unstructured":"Cheng B, Yu J (2019) Predictive value of diffusion-weighted MR imaging in early response to chemoradiotherapy of esophageal cancer: a meta-analysis. Dis Esophagus 32:1\u20136","DOI":"10.1093\/dote\/doy065"},{"key":"9627_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1148\/radiol.2532090027","volume":"253","author":"SH Kim","year":"2009","unstructured":"Kim SH, Lee JM, Hong SH et al (2009) Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 253:116\u2013125","journal-title":"Radiology"},{"key":"9627_CR22","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.ijrobp.2011.11.065","volume":"83","author":"S Yoshida","year":"2012","unstructured":"Yoshida S, Koga F, Kobayashi S et al (2012) Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 83:e21-27","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9627_CR23","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00330-021-08110-6","volume":"32","author":"K Kimura","year":"2022","unstructured":"Kimura K, Yoshida S, Tsuchiya J et al (2022) Usefulness of texture features of apparent diffusion coefficient maps in predicting chemoradiotherapy response in muscle-invasive bladder cancer. Eur Radiol 32:671\u2013679","journal-title":"Eur Radiol"},{"key":"9627_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/bju.15188","volume":"126","author":"F Del Giudice","year":"2020","unstructured":"Del Giudice F, Leonardo C, Simone G et al (2020) Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease? BJU Int 126:610\u2013619","journal-title":"BJU Int"},{"key":"9627_CR25","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1148\/radiol.2019182506","volume":"291","author":"H Wang","year":"2019","unstructured":"Wang H, Luo C, Zhang F et al (2019) Multiparametric MRI for bladder cancer: validation of VI-RADS for the detection of detrusor muscle invasion. Radiology 291:668\u2013674","journal-title":"Radiology"},{"key":"9627_CR26","doi-asserted-by":"crossref","unstructured":"Bricio TGM, Gouvea GL, Barros RV et al (2022) What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis. Cancer Imaging 22:20","DOI":"10.1186\/s40644-022-00459-1"},{"key":"9627_CR27","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1007\/s00261-022-03490-9","volume":"47","author":"A Delli Pizzi","year":"2022","unstructured":"Delli Pizzi A, Mastrodicasa D, Taraschi A et al (2022) Conspicuity and muscle-invasiveness assessment for bladder cancer using VI-RADS: a multi-reader, contrast-free MRI study to determine optimal b-values for diffusion-weighted imaging. Abdom Radiol (NY) 47:1862\u20131872","journal-title":"Abdom Radiol (NY)"},{"key":"9627_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00261-021-03383-3","volume":"47","author":"S Aslan","year":"2022","unstructured":"Aslan S, Cakir IM, Oguz U, Bekci T, Demirelli E (2022) Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion? Abdom Radiol (NY) 47:771\u2013780","journal-title":"Abdom Radiol (NY)"},{"key":"9627_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110282","volume":"151","author":"ASF Elshetry","year":"2022","unstructured":"Elshetry ASF, El-Fawakry RM, Hamed EM, Metwally MI, Zaid NA (2022) Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer. Eur J Radiol 151:110282","journal-title":"Eur J Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09627-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-09627-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-09627-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T15:12:46Z","timestamp":1691680366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-09627-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["9627"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-09627-8","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"5 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Yasuhisa Fujii.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"The study design was approved by the appropriate ethics review board, and written informed consent was obtained from each participant.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 diagnostic or prognostic study\u2022 multicenter study","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}